Figure 3.
Observed sirolimus concentrations (n=545) as part of the PK guided dosing in 44 patients with NF1 during the two-year trial period. Note: actual measured concentrations frequently were below the 10 ng/mL target as the time after the last dose often exceeded 12 hours or because of missed doses.